AstraZeneca (LSE:AZN) received EU approval for its cancer treatment Imfinzi, marking a significant product-related milestone.

Every bladder cancer journey is different, and no single treatment or diagnostic path fits everyone. According to patients who have experienced bladder cancer, the best care for you will depend on ...

UroGen Pharma Ltd. (NASDAQ:URGN) is one of the best hot stocks to buy according to Wall Street analysts. In mid-June, UroGen ...

Nine years after my bladder cancer diagnosis, I reflect on its recurrence, caregiving, grief, and my new life with leukemia ...

Bladder cancer may be scary but it will help to know that depending on the stage of cancer treatment will help control or ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Joseph Jacob, MD, discusses the promising impact of TAR-200.

Bladder cancer, often misunderstood, affects both men and women, not just the elderly. While smoking is a significant risk ...

In a multi-institutional study published in Science Direct, researchers revealed that testing urine-based tumor DNA (utDNA) ...

UK MHRA approves Serum Life Science Europe’s Anktiva to treat adult patients with non-muscle invasive bladder cancer: United Kingdom Monday, July 7, 2025, 12:00 Hrs [IST] The UK ...

Bladder Cancer is a disease where cancer cells form in the tissues of the bladder. More common in males than females over 55 ...

Beat bladder cancer with early detection! Expert insights reveal how a multidisciplinary approach can improve treatment outcomes in India. Learn more about effective care.